Combined therapy with anti-P-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in NK cell-depleted SCID mice.
about
The strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicityGenetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells.A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.Heterogeneous effects of M-CSF isoforms on the progression of MLL-AF9 leukemia.
P2860
Combined therapy with anti-P-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in NK cell-depleted SCID mice.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Combined therapy with anti-P-g ...... in NK cell-depleted SCID mice.
@en
Combined therapy with anti-P-g ...... in NK cell-depleted SCID mice.
@nl
type
label
Combined therapy with anti-P-g ...... in NK cell-depleted SCID mice.
@en
Combined therapy with anti-P-g ...... in NK cell-depleted SCID mice.
@nl
prefLabel
Combined therapy with anti-P-g ...... in NK cell-depleted SCID mice.
@en
Combined therapy with anti-P-g ...... in NK cell-depleted SCID mice.
@nl
P2093
P2860
P1476
Combined therapy with anti-P-g ...... in NK cell-depleted SCID mice.
@en
P2093
H Nokihara
M Hanibuchi
N Nishimura
Y Nishioka
P2860
P304
P356
10.1002/(SICI)1097-0215(19990702)82:1<105::AID-IJC18>3.0.CO;2-C
P577
1999-07-01T00:00:00Z